Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Bros. Advisors (gp) Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   608,718    

Indirect Shares

   158,658,441      
Direct Value   $43,376,298    

Indirect Value

   $12,816,169,206      
Total Shares   159,267,159      
Total Value   $12,859,545,503      


Incyte Corp $32,707,439 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327 Incyte Corp $32,707,439 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -75.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director, 10% Owner 2013-07-01 0 2019-02-27 9,235,362    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2014-03-05 0 2016-04-01 41,897,946    Premium*  
            Incyte Corp INCY Director, 10% Owner 2021-05-14 559,963 2021-05-14 29,367,926    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2014-05-22 0 2014-05-22 518,849    Premium*  
            Aceragen, Inc ACGN Director 2014-07-01 0 2016-01-04 78,885    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-01-07 1,020 2015-01-07 11,877,394    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2016-06-09 274 2016-06-09 30,003    Premium*  
            Intellia Therapeutics, Inc. NTLA Former 10% owner 2016-05-11 0 2016-05-11 976,214    Premium*  
            Invitae Corp NVTA 10% Owner 2016-11-17 0 2016-11-17 6,554,039    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2017-03-24 0 2023-11-22 2,168,818    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2023-05-31 46,557 2023-05-31 42,977,301    Premium*  
            Neurogene NGNE Director, 10% Owner 2023-10-05 904 2023-10-05 1,658,190    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 2022-05-16 0 2022-06-06 4,501,658    Premium*  
            Atreca Inc BCEL Former 10% Owner 2023-10-19 0 2023-10-19 2,971,128    Premium*  
            Igm Biosciences, Inc. IGMS 2023-12-13 0 2024-03-29 3,755,474    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-03-05 0 2024-03-05 89,254    Premium*  
* Premium Members only  

Records found :    103         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2019-02-26 4 OE $2.80 $112,000 I/I 40,000 29,288,793 0 -
INCY Incyte Corp Director   –       •       •   2021-05-14 4 OE $18.97 $758,800 I/I 40,000 29,334,516 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-28 4 S $70.55 $3,302,980 I/I (46,477) 9,092,565 0 -
INCY Incyte Corp Director   –       •       •   2016-02-24 4 B $69.70 $4,055,187 I/I 57,590 19,009,830 2.25 -
VTVT Vtv Therapeutics Inc.   –       •      –    2024-03-05 4 D $0.00 $0 I/I (57,657) 89,254 0 -
INCY Incyte Corp Director   –       •       •   2015-05-11 4 OE $7.68 $460,800 I/I 60,000 410,839 0 -
INCY Incyte Corp Director   –       •       •   2016-03-17 4 OE $3.86 $231,600 I/I 60,000 533,020 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-24 4 S $72.02 $5,718,588 I/I (79,403) 9,206,595 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-13 4 B $5.76 $520,776 I/I 87,316 2,977,836 0.01 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-16 4 S $76.35 $6,699,000 I/I (87,395) 10,672,645 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-25 4 S $72.20 $6,636,648 I/I (91,916) 9,130,859 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-28 4 B $9.62 $937,632 I/I 97,473 3,753,480 0.01 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-27 4 S $73.76 $10,269,089 I/I (138,610) 10,525,744 0 -
SGEN Seagen Inc Director   –       •       •   2019-06-06 4 A $0.00 $0 D/D 148,458 181,733 0 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2015-09-16 4 B $45.00 $6,750,000 I/I 150,000 2,744,052 1.5 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-14 4 B $6.50 $1,023,157 I/I 157,370 3,123,585 0.01 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2016-06-08 4 S $9.21 $1,456,480 I/I (158,100) 37,432 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2017-03-24 4 B $12.00 $1,999,992 I/I 166,666 4,527,089 1.5 -
NGNE Neurogene Director   –       •       •   2023-08-17 4 B $0.69 $115,617 I/I 166,942 5,612,949 2.25 -
NTLA Intellia Therapeutics, In... Former 10% owner   –       –      –    2016-05-11 4 B $18.00 $3,600,000 I/I 200,000 976,214 0.01 -
INCY Incyte Corp Director   –       •       •   2016-02-12 4 B $63.98 $14,010,424 I/I 208,677 18,346,124 2.25 -
NGNE Neurogene Director   –       •       •   2023-08-16 4 B $0.68 $156,254 I/I 229,600 5,458,724 2.25 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-26 4 B $8.26 $2,230,767 I/I 270,000 3,638,533 0.01 -
BCEL Atreca Inc Former 10% Owner   –       –      –    2023-10-19 4 S $0.40 $110,582 I/I (274,739) 2,971,128 0 %
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-15 4 B $6.36 $1,887,531 I/I 288,007 3,390,323 0.01 -
  103  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us